Large-Scale Antibody Purification Without Protein A Chromatography
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current industrial purification methods for monoclonal antibodies (mAbs) face high costs and efficiency bottlenecks, particularly due to the use of Protein A chromatography, which accounts for up to 80% of the total manufacturing cost and is not economically viable for large-scale production of diverse therapeutic mAbs.
Innovation Solution
A method involving hydrophobic chelators, non-ionic detergents, and metal ions is used to form aggregates that partition antibodies, allowing for their isolation without relying on Protein A chromatography, with the addition of hydrophobic amino acids or phospholipids to enhance extraction efficiency.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If Protein A chromatography is used for antibody purification, then high recovery yields and purity are achieved, but manufacturing cost increases significantly
Solution Approach 1:
The invention changes the chemical parameters of the purification system by using metal ions (Fe3+, Al3+, Ga3+) combined with hydrophobic ligands instead of Protein A. This parameter substitution maintains the ability to capture antibodies through coordinate bonding while eliminating the high cost associated with Protein A resin, thus resolving the contradiction between purification quality and manufacturing cost
Solution Approach 2:
The invention employs inexpensive metal salts and hydrophobic ligands that can be used in disposable cartridges or columns, replacing the expensive Protein A resin. These alternative materials are significantly cheaper while still providing effective antibody capture, thereby reducing manufacturing cost without sacrificing purification reliability
2Reliability
If Protein A chromatography is used as the primary capturing step, then high purity antibodies are obtained, but productivity is reduced due to cost constraints
Solution Approach 1:
By changing the chemical basis of antibody capture from Protein A affinity to metal ion-hydrophobic ligand coordination, the invention enables scalable purification processes that are not constrained by the high cost of Protein A. This allows for increased manufacturing throughput while maintaining antibody purity through the effective coordination chemistry of the metal ion systems
3Ease of operation
If non-ionic detergents are used to form aggregates with antibodies, then antibody partitioning is enabled, but antibody-aggregate interaction strength must be optimized
Solution Approach 1:
The invention creates a composite system combining non-ionic detergents with metal ions and hydrophobic ligands. The detergent forms the aggregate structure enabling partitioning, while the metal ion-hydrophobic ligand complex provides controlled interaction strength through coordinate bonding. This composite approach allows optimization of both partitioning efficiency and interaction strength simultaneously
Solution Approach 2:
The metal ion-hydrophobic ligand complex acts as an intermediary between the non-ionic detergent aggregate and the antibody. It mediates the interaction by providing specific coordination bonding that optimizes the strength of antibody-aggregate interaction, enabling effective partitioning while maintaining controllable binding strength
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach significantly improves antibody recovery yields and reduces costs, enabling efficient large-scale purification of monoclonal antibodies by weakening interactions between antibodies and detergent aggregates, thus overcoming the productivity bottleneck of traditional methods.
Implementation Method 1
contacting an aggregate comprising a hydrophobic chelator, at least one non-ionic detergent, metal ions and a non-detergent hydrophobic agent with a liquid sample comprising the antibody under conditions that allow partitioning of the antibody into the aggregate
Implementation Method 2
an aggregate comprising a hydrophobic chelator which has been solubilized in a non-volatile, water miscible organic solvent, at least one non-ionic detergent and metal ions
Data Source
AI summary
A method of isolating an antibody is disclosed. The method comprises contacting an aggregate comprising a hydrophobic chelator, at least one non-ionic detergent, metal ions and a non-detergent hydrophobic agent with a liquid sample comprising the antibody under conditions that allow partitioning of the antibody into the aggregate, thereby isolating the antibody. Kits for isolating antibodies are also disclosed.